The Story Behind Vaccine Maker Gritstone's Ch. 11

By Emily Lever · November 5, 2024, 10:16 PM EST

Vaccine maker Gritstone bio Inc. hit Chapter 11 after a tightening investment market left it starved of the capital it needed to keep doing its research into preventative treatments for cancer,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Petition

Case Information

Case Title

Gritstone bio, Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

October 10, 2024

Recent Articles By Emily

November 07, 2024
Blink Asks Court To OK Contested $121M Stalking Horse Sale
November 04, 2024
Del. Judge To Approve Avante Ch. 11 Financing
November 01, 2024
Avante Health Parent's Creditors Blast Ch. 11 Loan
November 01, 2024
MVP: Sullivan & Cromwell's Andy Dietderich
October 31, 2024
Reed Smith To Clarify Eletson Ties And Cut Fees $150K
October 30, 2024
Nuclear Energy Co. To Tap $10M Of $23M DIP
October 28, 2024
Creditors Get Ponzi Finding In Wash. Bankruptcy Trial
October 28, 2024
NY Youth Welfare Org Picks Up $4M Bid For 12-Acre Campus
October 25, 2024
Under The Radar: Bankruptcy News You May Have Missed
October 23, 2024
Meet The Attys In Truck Rental Co. Fluid Market's Ch. 11